In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results MAA Semaglutide and Cagrilintide vs Tirzepatide.docx Tirzepatide vs. Semaglutide: Which Is Better? New Leaf Online Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Evolving Role of Double and Triple Therapy With GLP 1 Receptor Agonists in Obesity and Cardiovascular Disease ScienceDirect Comparing the Big 3, Semaglutide, Tirzepatide and Retatrutide : r Mounjaro